The global poultry vaccines market share in 2026 size was valued at USD 1.32 billion in 2025 and is projected to grow from USD 1.38 billion in 2026 to USD 2.38 billion by 2034, exhibiting a CAGR of 6.99% during the forecast period. North America dominated the poultry vaccines market with a market share of 46.11% in 2025. The market is expanding as poultry producers increasingly focus on disease prevention, flock health, and biosecurity to support the growing demand for poultry meat and eggs.
Poultry vaccines play an important role in protecting birds against infectious diseases, including avian influenza, Newcastle disease, and Marek’s disease. Vaccination programs help poultry producers manage disease risks, maintain flock productivity, and reduce potential economic losses associated with outbreaks. Growing awareness of preventive animal healthcare and investments by manufacturers in vaccine research and development are also contributing to market expansion.
The market includes established animal health companies that focus on product development, vaccine launches, and geographic expansion. Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH are among the prominent participants. Competition is shaped by vaccine portfolios, research and development activities, and efforts to improve disease prevention across poultry populations.
Market Drivers